Evaluating the performance of polygenic risk profiling across diverse ancestry populations in Parkinson’s disease
View ORCID ProfilePaula Saffie-Awad, View ORCID ProfileInas Elsayed, View ORCID ProfileArinola O. Sanyaolu, View ORCID ProfilePeter Wild Crea, View ORCID ProfileArtur F Schumacher Schuh, Kristin S Levine, View ORCID ProfileDan Vitale, View ORCID ProfileMathew J Korestky, View ORCID ProfileJeffrey Kim, View ORCID ProfileThiago Peixoto Leal, View ORCID ProfileMaría Teresa Periñan, Sumit Dey, View ORCID ProfileAlastair J Noyce, View ORCID ProfileArmando Reyes-Palomares, View ORCID ProfileNoela Rodriguez-Losada, View ORCID ProfileJia Nee Foo, View ORCID ProfileWael Mohamed, View ORCID ProfileKarl Heilbron, View ORCID ProfileLucy Norcliffe-Kaufmann, the 23andMe Research Team, View ORCID ProfileMie Rizig, View ORCID ProfileNjideka Okubadejo, Mike Nalls, View ORCID ProfileCornelis Blauwendraat, View ORCID ProfileAndrew Singleton, View ORCID ProfileHampton Leonard, View ORCID ProfileMary B Makarious, View ORCID ProfileIgnacio F. Mata, View ORCID ProfileSara Bandres-Ciga the Global Parkinson’s Genetics Program (GP2)
doi: https://doi.org/10.1101/2023.11.28.23299090
Paula Saffie-Awad
1Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
2Centro de Trastornos del Movimiento (CETRAM), Santiago, Chile
3Clínica Santa María, Santiago, Chile
MDInas Elsayed
4Faculty of Pharmacy, University of Gezira, Wadmadani, 20, Sudan
PhDArinola O. Sanyaolu
5Department of Anatomy, College of Medicine, University of Lagos, Nigeria
PhDPeter Wild Crea
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
BScArtur F Schumacher Schuh
1Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
8Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
9Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
MD, PhDKristin S Levine
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
10Data Tecnica International LLC, Washington, DC, USA
MSDan Vitale
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
10Data Tecnica International LLC, Washington, DC, USA
MSMathew J Korestky
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
BScJeffrey Kim
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
BAThiago Peixoto Leal
11Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
PhDMaría Teresa Periñan
12Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
13Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
14Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
PhDSumit Dey
14Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
Alastair J Noyce
14Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
Armando Reyes-Palomares
15Department of Molecular Biology and Biochemistry, Faculty of Sciences, University of Málaga, Málaga, Spain
Noela Rodriguez-Losada
16Faculty of Education Sciences, University of Málaga, Málaga, Spain
PhDJia Nee Foo
17Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore
18Laboratory of Neurogenetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore
Wael Mohamed
19Neuroscience Unit, Clinical Pharmacology Dept., Menoufiia Medical School, Egypt
MD, PhDKarl Heilbron
2023andMe, Inc., Sunnyvale, CA, USA
PhDLucy Norcliffe-Kaufmann
2023andMe, Inc., Sunnyvale, CA, USA
PhDMie Rizig
14Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
21Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom
Njideka Okubadejo
22Department of Medicine, College of Medicine, University of Lagos, Nigeria
Mike Nalls
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
10Data Tecnica International LLC, Washington, DC, USA
PhDCornelis Blauwendraat
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
PhDAndrew Singleton
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
PhDHampton Leonard
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
10Data Tecnica International LLC, Washington, DC, USA
21Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom
MSMary B Makarious
7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
21Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom
BScIgnacio F. Mata
11Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
PhDSara Bandres-Ciga
6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
PhD
- Tables and supplementary tables and figures[supplements/299090_file03.zip]
Posted November 29, 2023.
Evaluating the performance of polygenic risk profiling across diverse ancestry populations in Parkinson’s disease
Paula Saffie-Awad, Inas Elsayed, Arinola O. Sanyaolu, Peter Wild Crea, Artur F Schumacher Schuh, Kristin S Levine, Dan Vitale, Mathew J Korestky, Jeffrey Kim, Thiago Peixoto Leal, María Teresa Periñan, Sumit Dey, Alastair J Noyce, Armando Reyes-Palomares, Noela Rodriguez-Losada, Jia Nee Foo, Wael Mohamed, Karl Heilbron, Lucy Norcliffe-Kaufmann, the 23andMe Research Team, Mie Rizig, Njideka Okubadejo, Mike Nalls, Cornelis Blauwendraat, Andrew Singleton, Hampton Leonard, Mary B Makarious, Ignacio F. Mata, Sara Bandres-Ciga
medRxiv 2023.11.28.23299090; doi: https://doi.org/10.1101/2023.11.28.23299090
Evaluating the performance of polygenic risk profiling across diverse ancestry populations in Parkinson’s disease
Paula Saffie-Awad, Inas Elsayed, Arinola O. Sanyaolu, Peter Wild Crea, Artur F Schumacher Schuh, Kristin S Levine, Dan Vitale, Mathew J Korestky, Jeffrey Kim, Thiago Peixoto Leal, María Teresa Periñan, Sumit Dey, Alastair J Noyce, Armando Reyes-Palomares, Noela Rodriguez-Losada, Jia Nee Foo, Wael Mohamed, Karl Heilbron, Lucy Norcliffe-Kaufmann, the 23andMe Research Team, Mie Rizig, Njideka Okubadejo, Mike Nalls, Cornelis Blauwendraat, Andrew Singleton, Hampton Leonard, Mary B Makarious, Ignacio F. Mata, Sara Bandres-Ciga
medRxiv 2023.11.28.23299090; doi: https://doi.org/10.1101/2023.11.28.23299090
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)